Text Size

The Prediction of Preeclampsia/Toxemia in Twin Pregnancy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2010 by Assaf-Harofeh Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Assaf-Harofeh Medical Center
ClinicalTrials.gov Identifier:
NCT01255202
First received: December 5, 2010
Last updated: December 6, 2010
Last verified: December 2010
History of Changes
  Purpose

The purpose of this study is to finout whetere uterinae artery flow , PP13 and endogolin levels in the serum and kongo red in the urine can predict preeclamsia toxemia in twin pregnancies.


Condition
Preeclampsia/Toxemia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prospective Longitudenal Study in the Prediction of Preeclampsia/Toxemia in Twin Pregnancy

Resource links provided by NLM:

MedlinePlus related topics: Sepsis
U.S. FDA Resources

Further study details as provided by Assaf-Harofeh Medical Center:

Biospecimen Retention:   Samples Without DNA

serum and urine


Estimated Enrollment: 200
Study Start Date: September 2009
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
twin preganacies

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

women with twin preganacy undergoing nuchal scan in our department

Criteria

Inclusion Criteria:

  • a women with a vaiable twin pregnany

Exclusion Criteria:

  • women with thrombophilya
  • women terated with anticoagolant
  • women with vascular disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01255202

Contacts
Contact: Ran Svirsky, MD 972-8-9779000 rsvirs@gmail.com

Locations
Israel
Assaf Harofe Medical Center Recruiting
Zrifin, Israel
Contact: Ran Svirsky, MD     972-8-9779000     rsvirs@gmail.com    
Principal Investigator: Ran Svirsky, MD            
Sponsors and Collaborators
Assaf-Harofeh Medical Center
  More Information

No publications provided

Responsible Party: Svirsky Ran, Assaf-Harofeh Medical Center
ClinicalTrials.gov Identifier: NCT01255202     History of Changes
Other Study ID Numbers: 189/09
Study First Received: December 5, 2010
Last Updated: December 6, 2010
Health Authority: Israel: Ethics Commission

Keywords provided by Assaf-Harofeh Medical Center:
preeclampsia
toxemia
twin
pregnancy
 pp13
prediction
kongo red

Additional relevant MeSH terms:
Pre-Eclampsia
Toxemia
Sepsis
Hypertension, Pregnancy-Induced
Pregnancy Complications
 Infection
Systemic Inflammatory Response Syndrome
Inflammation
Pathologic Processes

ClinicalTrials.gov processed this record on May 23, 2013